DMC/WSU Physician Identifies Cold Treatment That Protects Against Infant Disability and Death From Oxygen Loss
Posted on: Wednesday, 12 October 2005, 18:01 CDT
DETROIT, Oct. 12 /PRNewswire/ -- Lowering an infant's body temperature to about 92 degrees Fahrenheit within the first six hours of life reduces the chances for disability and death among infants who failed to receive enough oxygen or blood to the brain during birth. The research study findings appear in tomorrow's 2005 New England Journal of Medicine.
(Photo: http://www.newscom.com/cgi-bin/prnh/20051012/DEW030 )
The study involving 208 infants was led by Seetha Shankaran, M.D., Wayne State University professor of pediatrics and division director of neonatal- perinatal medicine at Children's Hospital of Michigan and Hutzel Women's Hospital. The research was conducted through the 16-site Neonatal Research Network (NRN), part of the National Institute of Child Health and Human Development (NICHD). The NICHD is one of the National Institutes of Health. (See list of NRN sites at the end.)
During the two-year study, researchers randomly enrolled qualifying infants from the NICHD neonatal sites. All infants had experienced oxygen deprivation during the birth process. Of the total 208 infants who took part in the study, 102 underwent the experimental cooling, or hypothermia, treatment, and 106 received standard care. Children's Hospital of Michigan and Hutzel Women's Hospital, combined, contributed 34 infants to the study, the most of any site. CHM/Hutzel participants included some infants who were transferred immediately after birth to CHM from other Michigan and Canadian hospitals.
Hypoxic ischemic encephalopathy (HIE) occurs when the brain fails to receive sufficient oxygen or sufficient blood before the infant is born. HIE may occur hours before birth, or, in some cases, during labor and delivery. The condition may result from a variety of causes. These include compression of the placenta, tearing of the placenta from the uterine wall before birth, compression of the umbilical cord and rupture of the uterus.
Standard care for HIE may involve placing the infant on a ventilator to assist breathing, monitoring blood pressure, providing fluids intravenously and other newborn intensive care supportive therapies.
The infants were cooled by placing them on a soft plastic blanket through which water circulates. The blanket's temperature is regulated by computer. For the study, the blankets were set at five degrees Celsius (41 degrees F). Each infant's temperature was lowered to 33.5 degrees C (92.3 degrees F), as measured by a temperature probe placed in each infant's esophagus. The infants in the hypothermia group were enrolled within the first six hours of birth and remained on the cooled blanket for 72 hours. After 72 hours had passed, they were gradually warmed to a normal body temperature.
Infants in both the hypothermia group and the control group received standard newborn intensive care, including monitoring of vital signs, and were watched carefully for signs of organ dysfunction.
When the infants were examined at 18 to 22 months of age, 44 percent from the hypothermia group developed a moderate to severe disability or had died as compared to 62 percent in the control group. This is a statistically significant difference between groups.
"The experimental cooling of newborns to prevent death and injury from oxygen deprivation during birth is extremely promising," said NICHD director Duane Alexander, M.D. "Yet it would be premature to institute the study results under any but the most carefully controlled and monitored circumstances."
According to Dr. Shankaran, "HIE is estimated to occur from 0.5 to 1 time per every 1,000 births."
The study also indicates that 10 percent of infants with moderate HIE die, as do 60 percent of infants with severe HIE. "Many, if not all, survivors of severe HIE are severely disabled," said Shankaran.
Previous studies, conducted on laboratory animals, suggested that cooling the brain from two to five degrees Celsius after HIE could reduce the chances for the death and disability that often result from HIE, the authors wrote.
Dr. Shankaran noted that the study's results are statistically valid only when all of the infants in the study are considered together as one group. When possible outcomes were evaluated separately, the differences between each outcome in the two groups of infants were not statistically significant.
However, in terms of the number of infants affected, trends in these data indicated that fewer infants in the hypothermia group died or experienced moderate or severe disability than was experienced by infants in the control group. For example, 24 infants in the hypothermia group died as compared to 38 in the control group. Similarly, 15 infants in the hypothermia group experienced disabling cerebral palsy compared to 19 infants in the control group. Five infants in the hypothermia group developed blindness as did nine in the control group. Infants in the hypothermia group also tended to score higher on measures of infant mental and physical development than infants in the control group.
Dr. Shankaran explained that it was not possible to recruit a large enough pool of infants to arrive at statistically significant measures for the differences in the various outcomes between the two groups. Because HIE occurs infrequently, it took three years to enroll a large enough number of infants to conduct the current study from the 16 participating NICHD Neonatal Research Network sites.
"A concern with any therapy that reduces mortality among infants at high risk of death and disability is the possibility of an increase in the number of infants who survive with disabilities," the study authors wrote. "In our study there was no evidence of increased rates of moderate or severe disability at 18 to 22 months of age among infants treated with hypothermia."
Side effects of the treatment consisted of hardening and drying of the skin where it came in contact with the cooling blanket, Dr. Shankaran said.
"Physicians need to exercise extreme caution in putting the study's results into practice," said Rose Higgins, M.D., program scientist for the NICHD Neonatal Research Network and an author of the study. "Most newborn intensive care units probably don't have the resources to duplicate the carefully controlled conditions of the study."
Dr. Higgins added that comparatively minor fluctuations in an infant's body temperature -- perhaps by as little as a few degrees -- could potentially result in serious harm if not closely monitored by trained personnel.
During the 72 hours of the hypothermia treatment, personnel trained in life support and the use of the cooling blanket monitored all infants continuously. Fluctuations in the infant's temperature were compensated for immediately by adjustments to the cooling blanket.
Moreover, only full-term infants took part in the study, Dr. Higgins said. It is not known whether preterm infants with HIE would benefit or be harmed from hypothermia treatment.
Dr. Higgins said that the NICHD is currently advising the American Academy of Pediatrics on the development of practice recommendations for treating infants with HIE. Moreover, three ongoing studies of hypothermia treatment are expected to provide additional information on the most effective ways to carry out the treatment.
Dr. Higgins added that the NICHD Neonatal Research Network also will follow both groups of children until they reach the ages of six or seven to learn if either group experiences any health problems or learning difficulties.
The Detroit Medical Center operates nine hospitals and institutions, including Children's Hospital of Michigan, Detroit Receiving Hospital, Harper University Hospital, Huron Valley-Sinai Hospital, Hutzel Women's Hospital, Kresge Eye Institute, Michigan Orthopaedic Specialty Hospital, Rehabilitation Institute of Michigan and Sinai-Grace Hospital.
Established as a nonprofit corporation in 1985, the Detroit Medical Center is a leading regional health care system with a mission of excellence in clinical care, research and medical education. The Detroit Medical Center is the academic health center for Wayne State University and its schools of medicine, nursing and allied health services. Wayne State University School of Medicine is the fourth largest medical school in the United States.
With more than 1,000 medical students, the Wayne State University School of Medicine is among the nation's largest institutions of its kind. Together with its clinical partners, the Wayne State University Physician Group, the Detroit Medical Center and other area health care providers, the school is a leader in medical research and patient care with emphases on cancer, maternal and child health, neurosciences, and population studies and urban health.
The NICHD is part of the National Institutes of Health (NIH), the biomedical research arm of the federal government. NIH is an agency of the U.S. Department of Health and Human Services. The NICHD sponsors research on development, before and after birth; maternal, child and family health; reproductive biology and population issues; and medical rehabilitation.
NICHD Neonatal Research Network (2005) Wayne State University NICHD Brown Medical School Case Western University Duke University Emory University Indiana University Stanford University University of Alabama University California, San Diego University of Cincinnati University of Miami University of Rochester University of Texas, Dallas University of Texas, Houston Wake Forest University Yale University Research Triangle Institute CONTACT: Sue Capatina (313) 745-1255
Photo: NewsCom: http://www.newscom.com/cgi-bin/prnh/20051012/DEW030AP Archive: http://photoarchive.ap.org/PRN Photo Desk, photodesk@prnewswire.com
Detroit Medical Center
CONTACT: Sue Capatina of Detroit Medical Center, +1-313-745-1255
Source: PRNewswire
Related Articles
- Maryland 'We Work for Health' Calls on Elected Officials to Focus on Medical Research and Innovation to Bolster Economy and Find Cures
- MAP Pharmaceuticals Announces Publication of MAP0004 Study in Current Medical Research and Opinion
- Praxis Launches Patient Recruitment Program for Women's Health Medical Research Studies
- Circulation Publishes Study From Masonic Medical Research Laboratory Suggesting a New Strategy for the Treatment of Atrial Fibrillation
- National Business Group on Health Selects University of Michigan's Health Management Research Center for EMPAQ(R) Data
- Lifetime Health Medical Group of Western New York to Provide Electronic Prescribing to 30,000 Additional Patients
- Oklahoma Medical Research Foundation Study Seeks Healthy Women
- Oklahoma Medical Research Foundation Scientists Receive $8 M to Study Flu Vaccine
- Oxford University and GE Healthcare Announce Cancer Research Collaboration; Study May Lead to Earlier Detection and Targeted Treatment of Colorectal Cancer
- Study: Medical Research Spending Jumps
User Comments (0)

RSS Feeds